gladiator solution
boumatic llc - lactic acid; sodium chlorite - solution - 2.64%; 0.64% - lactic acid 2.64%; sodium chlorite 0.64% - cattle
ultra dip lv solution
agrisan specialty chemical & pharmaceutical a division of agrisan inc - chlorhexidine acetate - solution - 0.5% - chlorhexidine acetate 0.5% - cattle
ukal-towel wipe
liberchem inc. - chlorhexidine acetate; alcohol anhydrous - wipe - 0.002%; 50% - chlorhexidine acetate 0.002%; alcohol anhydrous 50% - cattle
celebrex capsules
r-pharm germany gmbh - celecoxib - capsules - 200mg
celebrex capsules
r-pharm germany gmbh - celecoxib - capsules - 100mg
tanalised ecoseal timber preservative
arch wood protection (aust) pty limited - copper (cu) present as copper naphthenate; permethrin (25:75::cis:trans); liquid hydrocarbon - aerosol - copper (cu) present as copper naphthenate mineral-copper active 12.0 g/kg; permethrin (25:75::cis:trans) pyrethroid active 1.3 g/kg; liquid hydrocarbon solvent other 543.0 g/l - mixed function pesticide - cut/machined preservative treated timber | timber - freshly sawn | high risk situation | low risk situation | resistant timber | - decay prevention or preservation | gives longer life
atracurium besylate injection, solution
hospira, inc. - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate 10 mg in 1 ml - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
atracurium besylate injection, solution
sagent pharmaceuticals - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate 10 mg in 1 ml - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
atracurium besylate- atracurium besylate injection, solution
mylan institutional llc - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate 10 mg in 1 ml - atracurium besylate injection, usp is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.
amlodipine besylate tablet
dr reddy's laboratories - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine besylate 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. amlodipine besylate tablets are indicated for the symptomatic treatment of chronic stable angina. amlodipine besylate tablets may be used alone or in combination with other antianginal agents. amlodipine besylate tablets are indicated for the treatment of confirmed or suspected vasospastic angina. amlodipine besylate tablets may be used as monotherapy or in combination with other antianginal drugs. amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine.